Excessive topical application of Fabior Foam may lead to marked redness, peeling, or discomfort [see WARNINGS AND PRECAUTIONS. Management of accidental ingestion or excessive application to the skin should be as clinically indicated.
Fabior Foam is contraindicated in pregnancy.
Fabior Foam may cause fetal harm when administered to a pregnant woman. Tazarotene elicits teratogenic and developmental effects associated with retinoids after topical or systemic administration in rats and rabbits [see Use In Specific Populations].
If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, treatment should be discontinued and the patient apprised of the potential hazard to the fetus [see WARNINGS AND PRECAUTIONS and Use In Specific Populations].This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 5/24/2012
Additional Fabior Information
Report Problems to the Food and Drug Administration
Find out what women really need.